BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

Rhea-AI Summary

BIOLASE, Inc. (NASDAQ: BIOL) will release its fourth quarter and full-year 2020 financial results on March 25, 2021, after the U.S. markets close. A conference call and webcast will be held at 4:30 p.m. ET to discuss the results. Interested participants can join by dialing (800) 353-6461 in the U.S./Canada or (334) 323-0501 internationally, using Conference ID 7623727. An audio archive of the webcast will be available for 30 days on the BIOLASE website. BIOLASE is a leader in laser systems for dentistry, with over 41,200 systems sold worldwide.

FOOTHILL RANCH, Calif., March 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 353-6461. For international participants outside the U.S./Canada, the dial-in number is (334) 323-0501. For all callers, refer to the Conference ID 7623727. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-fourth-quarter-and-full-year-2020-results-on-march-25-2021-301249159.html

SOURCE BIOLASE, Inc.

FAQ

When will BIOLASE release its fourth quarter and full-year 2020 results?

BIOLASE will release its financial results on March 25, 2021, after the U.S. markets close.

What time is the BIOLASE conference call on March 25, 2021?

The BIOLASE conference call will take place at 4:30 p.m. ET on March 25, 2021.

How can I join the BIOLASE conference call?

To join the BIOLASE conference call, dial (800) 353-6461 in the U.S./Canada or (334) 323-0501 internationally, using Conference ID 7623727.

Will there be a webcast for the BIOLASE earnings release?

Yes, a webcast will be available, and an audio archive will be accessible for 30 days on the BIOLASE website.

What is the significance of BIOLASE's technology in dentistry?

BIOLASE's laser systems are known for their advanced technology, offering less pain and faster recovery for dental procedures.